Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study

被引:0
作者
Toni Maria Klein
Christine Blome
C. Elise Kleyn
Curdin Conrad
Paul G. Sator
Mona Ståhle
Kilian Eyerich
Marc Alexander Radtke
Christine Bundy
Myriam Cordey
Christopher E. M. Griffiths
Matthias Augustin
机构
[1] University Medical Center Hamburg-Eppendorf (UKE),Institute for Health Services Research in Dermatology and Nursing (IVDP)
[2] The University of Manchester,The Dermatology Centre, NIHR Manchester Biomedical Research Centre, Salford Royal Hospital
[3] Lausanne University Hospital CHUV and University of Lausanne,Department of Dermatology
[4] Clinic Hietzing,Department of Dermatology
[5] Karolinska Institutet,Unit of Dermatology, Department of Medicine
[6] Technical University of Munich,Department of Dermatology and Allergy
[7] Dermatologikum Hamburg,College of Biomedical and Health Sciences
[8] Cardiff University,undefined
[9] Amgen Europe GmbH,undefined
来源
Dermatology and Therapy | 2022年 / 12卷
关键词
Apremilast; Psoriasis; Patient Benefit Index; Patient-reported outcomes; Real-world study; Treatment satisfaction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:81 / 95
页数:14
相关论文
共 97 条
[1]  
Baliwag J(2015)Cytokines in psoriasis Cytokine 73 342-350
[2]  
Barnes DH(2005)Psoriasis: epidemiology, clinical features, and quality of life Ann Rheum Dis. 64 ii18-23
[3]  
Johnston A(2014)Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey J Am Acad Dermatol 70 871-881
[4]  
Langley RG(2012)Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life Acta Derm Venereol 92 299-303
[5]  
Krueger GG(2019)Dietary compounds as potential modulators of microRNA expression in psoriasis Ther Adv Chronic Dis 8 662047-1324
[6]  
Griffiths CE(2021)The molecular pathophysiology of psoriatic arthritis—the complex interplay between genetic predisposition, epigenetics factors, and the microbiome Front Mol Biosci. 33 1316-1120
[7]  
Lebwohl MG(2019)Pruritus characteristics in a large Italian cohort of psoriatic patients J Eur Acad Dermatol Venereol 29 1114-73
[8]  
Bachelez H(2015)Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study J Eur Acad Dermatol Venereol 64 66-151
[9]  
Barker J(2015)The immunogenetics of psoriasis: a comprehensive review J Autoimmun 90 147-1185
[10]  
Sampogna F(2010)Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany Acta Derm Venereol 100 adv00020-68